MarketPeel
Insider Trading Intelligence
HV

Houte Hans Van

NRIX
CHIEF FINANCIAL OFFICER · NURIX THERAPEUTICS, INC. · CIK 0001817217
FILING MIX · LIFETIME40%/60%
BUYS
59
SELLS
89
TOTAL VALUE
$4.57M
COMPANIES
1
ACTIVE SINCE
Feb 2021
HOLDINGS NOW
38,174
AVG SELL PX
$22.56
TRADE KIND
SHOWING 148 / 148
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
42 backtested trades · 8 horizons · 38 pending
Forward-return performance of every backtestable P/S trade by Houte Hans Van, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d42+69.05%-2.25%-0.16%-2.10%-3.11%-1.61
14d42+64.29%-0.47%+0.48%-0.80%-4.09%-0.44
30d42+66.67%-1.38%+1.44%-2.73%-6.70%-0.90
60d42+54.76%+5.20%+2.84%+2.36%-5.99%0.49
90d42(3 pending)+51.28%+2.50%+5.08%-2.58%-11.43%-0.52
180d42(5 pending)+59.46%+10.82%+10.59%+0.23%-20.94%0.03
1y42(9 pending)+66.67%+2.50%+17.44%-14.95%-51.30%-1.11
2y42(21 pending)+38.10%+12.45%+31.63%-19.18%-15.18%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NRIX · 38,174 shares · as of May 5, 2026
037,50075,000112,500150,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 59 buys / 89 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
582$17.18$10.0K37,592May 5, 2026May 5, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,473$16.58$223.3K38,174May 5, 2026May 5, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,0000Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,388$16.65$39.7K51,647Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75051,177Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00047,427Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,85854,035Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75015,000Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,85822,867Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
93,75093,750Feb 10, 2026Feb 10, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,87542,875Feb 10, 2026Feb 10, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,588$16.58$59.5K45,500Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88740,479Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,8870Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
73$17.37$1.3K45,427Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,0002,000Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00042,479Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75046,229Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,85925,725Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,85949,088Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75018,750Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,284$12.56$78.9K37,592Nov 3, 2025Nov 3, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,130$12.80$40.1K43,876Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88638,398Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,8862,887Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75044,148Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00040,398Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,85828,584Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75022,500Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,0004,000Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,85847,006Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,402$11.03$59.6K35,512Aug 1, 2025Aug 1, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88636,610Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,8865,773Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
4,304$12.01$51.7K40,914Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,85845,218Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75026,250Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00038,610Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75042,360Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,0006,000Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,85831,442Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,198$11.33$70.2K33,724May 2, 2025May 2, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,8868,659Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88636,610Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00038,610Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75042,360Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,438$11.50$28.0K39,922Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75030,000Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,0008,000Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,125$14.40$73.8K34,424Mar 3, 2025Mar 3, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
700$15.13$10.6K33,724Mar 3, 2025Mar 3, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Feb 11, 2025Feb 13, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
34,30034,300Feb 11, 2025Feb 13, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88611,545Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00038,610Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88636,610Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75042,360Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,557$19.81$50.6K39,803Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
254$20.33$5.2K39,549Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,00010,000Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75033,750Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,546$24.28$86.1K33,724Nov 1, 2024Nov 1, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75039,638Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,00012,000Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75037,500Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00035,888Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,368$24.31$57.6K37,270Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88614,431Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88633,888Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,000$25.22$504.4K31,002Aug 26, 2024Aug 26, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,377$21.43$72.4K51,102Aug 1, 2024Aug 1, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$22.22$2.2K51,002Aug 1, 2024Aug 1, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00053,219Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,490$20.67$51.5K54,479Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,75041,250Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,00014,000Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,75056,969Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88617,317Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88651,219Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,000$20.01$400.2K48,333Jun 20, 2024Jun 20, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,499$12.83$44.9K68,333May 2, 2024May 2, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00073,219Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,00016,000Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88620,203Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88671,219Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,387$12.04$16.7K71,832Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,812$10.02$68.2K68,333Feb 16, 2024Feb 16, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000150,000Feb 13, 2024Feb 15, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,00045,000Feb 13, 2024Feb 15, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,671$7.99$13.4K75,145Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88623,089Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88674,816Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,00018,000Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00076,816Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,541$10.00$35.4K71,930Dec 20, 2023Dec 21, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,906$10.00$109.1K75,471Dec 19, 2023Dec 20, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,080$5.20$5.6K86,377Oct 31, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00087,457Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,00020,000Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88685,457Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88625,975Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,245$9.65$12.0K82,571Jul 31, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,00083,816Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,00022,000Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88628,861Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88681,816Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
721$9.88$7.1K78,930May 1, 2023May 2, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88631,747Apr 30, 2023May 2, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88679,651Apr 30, 2023May 2, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
88,90088,900Feb 14, 2023Feb 15, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,00024,000Feb 14, 2023Feb 15, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
924$11.78$10.9K76,765Jan 30, 2023Feb 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88634,633Jan 30, 2023Feb 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88677,689Jan 30, 2023Feb 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
739$12.88$9.5K74,803Oct 31, 2022Nov 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88675,542Oct 30, 2022Nov 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88637,519Oct 30, 2022Nov 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
120,000120,000Aug 9, 2022Aug 10, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
752$15.67$11.8K72,656Aug 1, 2022Aug 2, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88640,405Jul 30, 2022Aug 2, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,88673,408Jul 30, 2022Aug 2, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
68,3330May 31, 2022Jun 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
68,333$0.84$57.4K70,522May 31, 2022Jun 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
697$11.75$8.2K2,189May 2, 2022May 3, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,88643,291Apr 30, 2022May 3, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
2,8862,886Apr 30, 2022May 3, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
46,17746,177Jan 19, 2022Jan 21, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
103,894103,894Jan 19, 2022Jan 21, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
13,197$1.86$24.5K33,590Feb 24, 2021Feb 25, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
20,393$1.20$24.5K20,393Feb 24, 2021Feb 25, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
20,3939,027Feb 24, 2021Feb 25, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
1,829$7.26$13.3K35,419Feb 24, 2021Feb 25, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
35,419$39.90$1.41M0Feb 24, 2021Feb 25, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
13,19720,136Feb 24, 2021Feb 25, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,82936,504Feb 24, 2021Feb 25, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,91329,420Feb 22, 2021Feb 23, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
5,330$39.93$212.8K0Feb 22, 2021Feb 23, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
1,417$0.84$1.2K1,417Feb 22, 2021Feb 23, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
3,913$1.20$4.7K5,330Feb 22, 2021Feb 23, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,41768,333Feb 22, 2021Feb 23, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,652$35.10$128.2K6,791Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
5,725$36.00$206.1K1,066Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
400$38.05$15.2K0Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
3,140$34.24$107.5K10,443Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
13,58369,750Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Financial Officer
666$36.91$24.6K400Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
13,583$0.84$11.4K13,583Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 11, 2021Feb 12, 2021View →
Other insiders · NRIX
Loading peer insiders…
About this filer
CIK 0001817217
ROLE
Chief Financial Officer
PRIMARY
NRIX
COMPANIES
1
ACTIVE SINCE
Feb 2021
MARKETPEEL · /INSIDER/0001817217DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback